Iwaniec T - Search Results

1

Decreased protein C activity, lower ADAMTS13 antigen and free protein S levels accompanied by unchanged thrombin generation potential in hospitalized COVID-19 patients.

Wójcik K, Bazan-Socha S, Celejewska-Wójcik N, Górka K, Lichołai S, Polok K, Stachura T, Zaręba L, Dziedzic R, Gradzikiewicz A, Sanak M, Musiał J, Sładek K, Iwaniec T. Wójcik K, et al. Among authors: iwaniec t. Thromb Res. 2023 Mar;223:80-86. doi: 10.1016/j.thromres.2023.01.016. Epub 2023 Jan 24. Thromb Res. 2023. PMID: 36709678 Free PMC article.

2

Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.

Musial J, Swadzba J, Motyl A, Iwaniec T. Musial J, et al. Among authors: iwaniec t. J Rheumatol. 2003 Apr;30(4):723-30. J Rheumatol. 2003. PMID: 12672190

3

Valine/Leucine247 polymorphism of beta2-glycoprotein I in patients with antiphospholipid syndrome: lack of association with anti-beta2-glycoprotein I antibodies.

Swadzba J, Sanak M, Iwaniec T, Dziedzina S, Musiał J. Swadzba J, et al. Among authors: iwaniec t. Lupus. 2006;15(4):218-22. doi: 10.1191/0961203306lu2288oa. Lupus. 2006. PMID: 16686261

4

[Antiphospholipid syndrome in autoimmune diseases].

Swadźba J, Iwaniec T, Wilańska J, Musiał J. Swadźba J, et al. Among authors: iwaniec t. Pol Arch Med Wewn. 2006 May;115(5):432-7. Pol Arch Med Wewn. 2006. PMID: 17195356 Polish.

5

Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases.

Swadźba J, Iwaniec T, Szczeklik A, Musiał J. Swadźba J, et al. Among authors: iwaniec t. J Thromb Haemost. 2007 Sep;5(9):1883-9. doi: 10.1111/j.1538-7836.2007.02669.x. Epub 2007 Jun 26. J Thromb Haemost. 2007. PMID: 17596131 Free article.

6

Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state.

Swadzba J, Iwaniec T, Musial J. Swadzba J, et al. Among authors: iwaniec t. Rheumatol Int. 2011 Mar;31(3):307-13. doi: 10.1007/s00296-009-1314-8. Epub 2009 Dec 15. Rheumatol Int. 2011. PMID: 20012959

7

The influence of simvastatin on selected inflammatory markers in patients with chronic obstructive pulmonary disease.

Kaczmarek P, Sładek K, Skucha W, Rzeszutko M, Iwaniec T, Dziedzina S, Szczeklik A. Kaczmarek P, et al. Among authors: iwaniec t. Pol Arch Med Wewn. 2010;120(1-2):11-7. Pol Arch Med Wewn. 2010. PMID: 20150839 Free article. Clinical Trial.

8

Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow).

Celinska-Lowenhoff M, Iwaniec T, Alhenc-Gelas M, Musial J, Undas A. Celinska-Lowenhoff M, et al. Among authors: iwaniec t. Thromb Haemost. 2011 Aug;106(2):379-81. doi: 10.1160/TH11-02-0066. Epub 2011 Jun 9. Thromb Haemost. 2011. PMID: 21655678 No abstract available.

9

Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines.

Swadzba J, Iwaniec T, Pulka M, De Laat B, De Groot PG, Musial J. Swadzba J, et al. Among authors: iwaniec t. J Thromb Haemost. 2011 Sep;9(9):1776-83. doi: 10.1111/j.1538-7836.2011.04420.x. J Thromb Haemost. 2011. PMID: 21707912 Free article.

10

Antithrombin Krakow II (c.624+1 G > T): a novel mutation leading to type 1 antithrombin deficiency.

Celinska-Löwenhoff M, Iwaniec T, Alhenc-Gelas M, Musial J, Undas A. Celinska-Löwenhoff M, et al. Among authors: iwaniec t. Blood Coagul Fibrinolysis. 2012 Jul;23(5):454-5. doi: 10.1097/MBC.0b013e32835361a7. Blood Coagul Fibrinolysis. 2012. PMID: 22498983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters